Table 7 One-way (univariate) sensitivity analysis
Parameter | "Early" treatment | "Late" treatment | Difference (€) | C/E analysis result |
|---|---|---|---|---|
Base case | Dominant | |||
MV and/or death < 7 days, (%)* | 21 | 63 | -42 | |
Average cost per treated patient (€) | 4,901.70 | 4,960.07 | - 58.37 | |
Variation in Mechanical Ventilation cost | ||||
- plus 15% compared to base case (€) | 4,918.03 | 4,998.95 | - 80.93 | Dominant |
- minus 15% compared to base case (€) | 4,885.37 | 4,921.18 | - 35.81 | Dominant |
- plus 30% compared to base case (€) | 4,934.35 | 5,037.84 | -103.49 | Dominant |
- minus 30% compared to base case (€) | 4,869.05 | 4,882.29 | - 13.25 | Dominant |
Variation in NCPAP cost | ||||
- plus 15% compared to base case (€) | 5,551.85 | 5,618.43 | - 133.57 | Dominant |
- minus 15% compared to base case (€) | 4,251.55 | 4,301.70 | - 50.16 | Dominant |
- plus 30% compared to base case (€) | 6,202.01 | 6,276.79 | - 74.78 | Dominant |
- minus 30% compared to base case (€) | 3,601.39 | 3,643.34 | - 41.95 | Dominant |
% ET patients with MV | ||||
- plus 15% compared to base case (€) | 4,918.03 | 4,960.07 | - 42.04 | Dominant |
- plus 30% compared to base case (€) | 4,934.35 | 4,960.07 | - 25.71 | Dominant |
- plus 50% compared to base case (€) | 4,956.12 | 4,960.07 | - 3.94 | Dominant |
ET patient days in MV | ||||
- plus 15% compared to base case (€) | 4,914.39 | 4,960.07 | - 45.68 | Dominant |
- plus 30% compared to base case (€) | 4,927.08 | 4,960.07 | - 32.99 | Dominant |
- plus 50% compared to base case (€) | 4,944.00 | 4,960.07 | - 16.07 | Dominant |